The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen tre...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:60d7f9aa2a1d4fc7927d438ff4fb340e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:60d7f9aa2a1d4fc7927d438ff4fb340e2021-11-25T18:39:52ZThe Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica10.3390/ph141111661424-8247https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1166https://doaj.org/toc/1424-8247(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen treatment-naïve PMR patients completed the study. Patients underwent a 5-day protocol, receiving 2 min of t-VNS stimulation bilaterally on the neck, three times daily. Cardiac vagal tone (CVT) measured on a linear vagal scale (LVS), blood pressure, heart rate, patient-reported outcome, and biochemical changes were assessed. (3) t-VNS induced a 22% increase in CVT at 20 min after initial stimulations compared with baseline (3.4 ± 2.2 LVS vs. 4.1 ± 2.9 LVS, <i>p</i> = 0.02) and was accompanied by a 4 BPM reduction in heart rate (73 ± 11 BPM vs. 69 ± 9, <i>p</i> < 0.01). No long-term effects were observed. Furthermore, t-VNS induced a 14% reduction in the VAS score for the hips at day 5 compared with the baseline (5.1 ± 2.8 vs. 4.4 ± 2.8, <i>p</i> = 0.04). No changes in CRP or proinflammatory analytes were observed. (4) t-VNS modulates the autonomic nervous system in patients with PMR, but further investigation of t-VNS in PMR patients is warranted.Jacob VenborgAnne-Marie WegebergSalome KristensenBirgitte BrockChristina BrockMogens Pfeiffer-JensenMDPI AGarticlepolymyalgia rheumaticavagus nerve stimulationinflammatory responsePMRt-vnsMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1166, p 1166 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns Medicine R Pharmacy and materia medica RS1-441 |
spellingShingle |
polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns Medicine R Pharmacy and materia medica RS1-441 Jacob Venborg Anne-Marie Wegeberg Salome Kristensen Birgitte Brock Christina Brock Mogens Pfeiffer-Jensen The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
description |
(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen treatment-naïve PMR patients completed the study. Patients underwent a 5-day protocol, receiving 2 min of t-VNS stimulation bilaterally on the neck, three times daily. Cardiac vagal tone (CVT) measured on a linear vagal scale (LVS), blood pressure, heart rate, patient-reported outcome, and biochemical changes were assessed. (3) t-VNS induced a 22% increase in CVT at 20 min after initial stimulations compared with baseline (3.4 ± 2.2 LVS vs. 4.1 ± 2.9 LVS, <i>p</i> = 0.02) and was accompanied by a 4 BPM reduction in heart rate (73 ± 11 BPM vs. 69 ± 9, <i>p</i> < 0.01). No long-term effects were observed. Furthermore, t-VNS induced a 14% reduction in the VAS score for the hips at day 5 compared with the baseline (5.1 ± 2.8 vs. 4.4 ± 2.8, <i>p</i> = 0.04). No changes in CRP or proinflammatory analytes were observed. (4) t-VNS modulates the autonomic nervous system in patients with PMR, but further investigation of t-VNS in PMR patients is warranted. |
format |
article |
author |
Jacob Venborg Anne-Marie Wegeberg Salome Kristensen Birgitte Brock Christina Brock Mogens Pfeiffer-Jensen |
author_facet |
Jacob Venborg Anne-Marie Wegeberg Salome Kristensen Birgitte Brock Christina Brock Mogens Pfeiffer-Jensen |
author_sort |
Jacob Venborg |
title |
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
title_short |
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
title_full |
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
title_fullStr |
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
title_full_unstemmed |
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica |
title_sort |
effect of transcutaneous vagus nerve stimulation in patients with polymyalgia rheumatica |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e |
work_keys_str_mv |
AT jacobvenborg theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT annemariewegeberg theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT salomekristensen theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT birgittebrock theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT christinabrock theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT mogenspfeifferjensen theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT jacobvenborg effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT annemariewegeberg effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT salomekristensen effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT birgittebrock effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT christinabrock effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica AT mogenspfeifferjensen effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica |
_version_ |
1718410837559869440 |